You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CBIO Buy Disclosure
Fairmount Funds Management Llc · SEC Form 4 · Filed Jul 20, 2026
Buy
Calculated transaction value
$7.62M
Fairmount Funds Management Llc Director / Ten Percent Owner
CBIO
Transaction date
Jul 16, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 4 days later
CBIO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Pre-Funded Warrant (Right to Buy) on Ordinary Shares
- Quantity / price
- 525,897 shares @ $14.5
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001104659-26-085113
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$20M
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crescent Biopharma, Inc. CBIO | Buy | Jul 16, 2026 | $12.38M |
| Crescent Biopharma, Inc. CBIO Current | Buy | Jul 16, 2026 | $7.62M |